Artwork

Content provided by Spencer McKeown and Josh Taylor, Spencer McKeown, and Josh Taylor. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Spencer McKeown and Josh Taylor, Spencer McKeown, and Josh Taylor or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Navigating the Future of Cancer Treatment: A Conversation with Nelson Pace

21:18
 
Share
 

Manage episode 414084602 series 2892435
Content provided by Spencer McKeown and Josh Taylor, Spencer McKeown, and Josh Taylor. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Spencer McKeown and Josh Taylor, Spencer McKeown, and Josh Taylor or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In Episode 034 of the #kilnroadtrip, created and produced by The Swell Pod, hosts Spencer McKeown and Josh Taylor interview Nelson Pace, an epidemiologist and data scientist at AbbVie, during their Kiln Road Trip. They discuss Nelson's career in cancer research, the development of cancer therapies, and the impact of his work on patient outcomes. Nelson shares his experience working on a therapy called Moxley for lymphoma and reflects on the advancements in cancer treatment over the years. He also talks about his current projects, including therapies for elderly patients, and expresses optimism for the future of cancer care. Nelson's journey in biotech is highlighted as both unique and impactful.

Check out today’s episode and every other installment of the Kiln.Roadtrip by listening, watching, and subscribing to the podcast here - https://linktr.ee/theswellpod

Location: Kiln. Provo

The Kiln Road Trip: Uncovering Deep Truths with 100 Pleasantly Rebellious Humans. 10 days. 5 States. 3,580 Miles.100 Interviews! Daily episodes starting on March 5, Monday to Friday, for the next 100 days, followed by a short documentary and a book about the journey.

Thank you to the partners and sponsors who made the kiln.roadtrip possible: KILN, MOTERRA, TORUS

And thank you to the crew who helped us document and share the journey: DENISSE LEON, TY COTTLE, NATHAN CLARK, FINDLAY MCKEOWN

Bullets:

  • Interview with Nelson Pace, an epidemiologist and real-world data scientist at AbbVie
  • Nelson's work in cancer research and the challenges and opportunities in developing and testing cancer therapies
  • The hosts' discussion with Nelson about his career and the impact of his work
  • Nelson's expertise in understanding the causality of exposure or treatment and its effect on health outcomes
  • Nelson's work on developing cancer therapies and taking drugs from inception to market
  • Advancements in cancer treatment and improved outcomes for patients
  • Nelson's unique career path and family influence
  • Nelson's work at AbbVie and his current projects in leading studies to test the safety and efficacy of cancer therapies

Timestamps:

The kiln road trip (00:00:01) Introduction to the podcast's journey across five states and purpose of interviewing 100 individuals.

Nelson Pace's work at AbbVie (00:00:52) Introduction to Nelson Pace, an epidemiologist and real-world data scientist, and his work at AbbVie in cancer research and therapy development.

Impact of cancer therapies (00:02:25) Discussion on the impact of cancer therapies, improvements in survival rates, and the significance of developing new treatments.

Nelson Pace's career path (00:04:20) Nelson Pace's journey into cancer research and his transition from biostatistics to epidemiology and biotech.

Nelson Pace's work at AbbVie (00:05:34) Introduction to AbbVie, Nelson Pace's employer, and its role in cancer research and therapy development.

Challenges in clinical trials (00:09:24) Discussion on the logistical aspects and challenges of running clinical trials, including data collection and study design.

Data sharing and patient consent (00:11:26) Challenges related to data sharing and patient consent in clinical trials and research.

Developing something new in biotech (00:16:06) Discussion on the challenges and timelines of developing new ideas and therapies in the biotech and pharmaceutical industry.

Future of cancer treatments (00:18:56) Optimistic outlook on the future of cancer treatments, including opportunities for curing, stopping, and reversing the disease.

Conclusion of the interview (00:20:03) Closing remarks and gratitude for Nelson Pace's work and contribution to the field of cancer research.

Tags:

#SwellPod, #KilnRoadTrip, #Kiln, #MotorraCamperVans, #podcast, #interview, #innovation, #resilience, #communitybuilding, #passion, #purpose, #community, #diversity, #collaboration, #thoughtleadership, #100interviews, #entrepreneur, #CEO, #leadership

  continue reading

101 episodes

Artwork
iconShare
 
Manage episode 414084602 series 2892435
Content provided by Spencer McKeown and Josh Taylor, Spencer McKeown, and Josh Taylor. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Spencer McKeown and Josh Taylor, Spencer McKeown, and Josh Taylor or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In Episode 034 of the #kilnroadtrip, created and produced by The Swell Pod, hosts Spencer McKeown and Josh Taylor interview Nelson Pace, an epidemiologist and data scientist at AbbVie, during their Kiln Road Trip. They discuss Nelson's career in cancer research, the development of cancer therapies, and the impact of his work on patient outcomes. Nelson shares his experience working on a therapy called Moxley for lymphoma and reflects on the advancements in cancer treatment over the years. He also talks about his current projects, including therapies for elderly patients, and expresses optimism for the future of cancer care. Nelson's journey in biotech is highlighted as both unique and impactful.

Check out today’s episode and every other installment of the Kiln.Roadtrip by listening, watching, and subscribing to the podcast here - https://linktr.ee/theswellpod

Location: Kiln. Provo

The Kiln Road Trip: Uncovering Deep Truths with 100 Pleasantly Rebellious Humans. 10 days. 5 States. 3,580 Miles.100 Interviews! Daily episodes starting on March 5, Monday to Friday, for the next 100 days, followed by a short documentary and a book about the journey.

Thank you to the partners and sponsors who made the kiln.roadtrip possible: KILN, MOTERRA, TORUS

And thank you to the crew who helped us document and share the journey: DENISSE LEON, TY COTTLE, NATHAN CLARK, FINDLAY MCKEOWN

Bullets:

  • Interview with Nelson Pace, an epidemiologist and real-world data scientist at AbbVie
  • Nelson's work in cancer research and the challenges and opportunities in developing and testing cancer therapies
  • The hosts' discussion with Nelson about his career and the impact of his work
  • Nelson's expertise in understanding the causality of exposure or treatment and its effect on health outcomes
  • Nelson's work on developing cancer therapies and taking drugs from inception to market
  • Advancements in cancer treatment and improved outcomes for patients
  • Nelson's unique career path and family influence
  • Nelson's work at AbbVie and his current projects in leading studies to test the safety and efficacy of cancer therapies

Timestamps:

The kiln road trip (00:00:01) Introduction to the podcast's journey across five states and purpose of interviewing 100 individuals.

Nelson Pace's work at AbbVie (00:00:52) Introduction to Nelson Pace, an epidemiologist and real-world data scientist, and his work at AbbVie in cancer research and therapy development.

Impact of cancer therapies (00:02:25) Discussion on the impact of cancer therapies, improvements in survival rates, and the significance of developing new treatments.

Nelson Pace's career path (00:04:20) Nelson Pace's journey into cancer research and his transition from biostatistics to epidemiology and biotech.

Nelson Pace's work at AbbVie (00:05:34) Introduction to AbbVie, Nelson Pace's employer, and its role in cancer research and therapy development.

Challenges in clinical trials (00:09:24) Discussion on the logistical aspects and challenges of running clinical trials, including data collection and study design.

Data sharing and patient consent (00:11:26) Challenges related to data sharing and patient consent in clinical trials and research.

Developing something new in biotech (00:16:06) Discussion on the challenges and timelines of developing new ideas and therapies in the biotech and pharmaceutical industry.

Future of cancer treatments (00:18:56) Optimistic outlook on the future of cancer treatments, including opportunities for curing, stopping, and reversing the disease.

Conclusion of the interview (00:20:03) Closing remarks and gratitude for Nelson Pace's work and contribution to the field of cancer research.

Tags:

#SwellPod, #KilnRoadTrip, #Kiln, #MotorraCamperVans, #podcast, #interview, #innovation, #resilience, #communitybuilding, #passion, #purpose, #community, #diversity, #collaboration, #thoughtleadership, #100interviews, #entrepreneur, #CEO, #leadership

  continue reading

101 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide